haMSter: a Novel Smartphone Communication Tool for People With MS

Not Applicable

Completed

• Conditions: Multiple Sclerosis; M-health
• Interventions: Device: haMSter smartphone app

• Registration Number: NCT04555863
• Lead Sponsor: Medical University of Vienna

Brief Summary

haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone.

Endpoints include the adherence to this app and satisfaction with this Intervention.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-01
• Study First Submitted: 2020-09-14
• Study First Submitted QC: 2020-09-14
• Study First Posted: 2020-09-21
• Primary Completion: 2021-04-01
• Study Completion: 2021-06-01
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-12
• Last Update Posted: 2021-10-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Any MS according to MacDonald criteria
• informed consent

Read More

Exclusion Criteria

• language barriers

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
haMSter app	haMSter smartphone app	Patients receiving the app for personal use for 6 months

Primary Outcome Measures

Name	Time	Method
adherence to device	over the course of this study (over 6 months)	Percentage (Number) of participants having completed all necessary questionnaires per study period. Max: 6 completions.

Secondary Outcome Measures

Name	Time	Method
General satisfaction with specific Features of the haMSter app	after study completion (after 6 months)	Empirical questionnaires. We will Report frequencies of answers given. There is no Overall score in a larger sense.
Overall satisfaction with this application in telemedicine	after study completion (after 6 months)	TMPQ (Telemedicine Perception Questionnaire). Min: 0 points. Max: 80 Points. Higher scores indicate a better outcome

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria